Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ARENA PHARMACEUTICALS INC
| Metric | ARENA PHARMACEUTICALS INC Healthcare |
|---|---|
| Quality Score | 40 / 100 |
| Revenue (latest) | $54,000 |
| Net income (latest) | −$616M |
| Operating margin | −1156109.3% |
| Net margin | −1141542.6% |
| Return on equity | −91.6% |
| Return on assets | −78.6% |
| Return on capital (ROCE) | −86.9% |
| Debt / equity | — |
| Revenue growth (YoY) | −83.1% |
| Altman Z″ (distress) | — |
| Accruals / assets | −21.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.